VRX : Analysis & Opinions

  1. Pharma Stocks Prone to Decline From Democratic Win (MYL, ARIA)

    October 17, 2016
    Amid the political bashing of price raises by drug manufacturers, here are the stocks most prone to declines.
  2. How Valeant’s Scandal Has Impacted Its Stock Price (VRX)

    September 30, 2016
    Since its peak price on August 5, 2015, Valeant’s shares have lost 86% of their value.
  3. Revisiting Three Market Villains (CMG, VRX)

    September 27, 2016
    Mylan, Chipotle, and Valeant Pharmaceuticals CEOs have learned that traders have the final word when executives fail to address ...
  4. Wealth Preservation: "All I Know Is That I Know Nothing"

    September 25, 2016
    Investors can derive great value from humility. By keeping the adage "all I know is that I know nothing" in mind, they can ...
  5. Ackman's Pershing Square Bets on Chipotle (CMG, VRX)

    September 7, 2016
    The activist hedge fund mogul's bullish stance on Chipotle has sent shares up 4.8% at open Wednesday
  6. Is Mylan The Next Valeant Trade? (MYL, VRX)

    September 2, 2016
    Mylan is caught in a political firestorm after EpiPen price increases while short sellers drool over a possible Valeant Pharmaceuticals ...
  7. Bill Ackman's Cry: "Worst Period Of Performance" (HLN, VRX)

    August 31, 2016
    Pershing Square Holding’s year-to-date performance is -15.5%.
  8. Valeant International Sued For Alleged Racketeering (VRX)

    August 29, 2016
    The class action suit claims that Valeant overcharged the buyers for prescription drugs by hiding its relationship with Philidor ...
  9. Pershing Square Cuts Positions to Fight Losses (VRX, ZTS)

    August 21, 2016
    Bill Ackman's fund, attempting to deal with significant losses, cuts positions in major stakes.
  10. T. Rowe Price Sues Valeant Pharmaceuticals For Fraud (TROW, VRX)

    August 19, 2016
    T. Rowe Price has launched a lawsuit against Valeant Pharmaceuticals, claiming it committed fraud that cost it and other ...
  11. Valeant Shares Plunge Amid Criminal Probe (VRX)

    August 10, 2016
    Federal prosecutors have launched a criminal investigation to determine whether Valeant defrauded insurers.
  12. 8 Stocks for Active Traders (VRX,FCX,F,BAC,SIRI)

    August 10, 2016
    These eight stocks have the potential to deliver significant returns in a short period of time.
  13. Valeant Q2 Earnings: What to Expect

    August 8, 2016
    Wall Street expects the embattled drug company to deliver year-over-year declines in both earnings and revenue.
  14. Ackman's Bad Bets Costs $600 Million in Redemptions

    July 24, 2016
    If Ackman's losing streak continues, his investors may begin to factor in their own poor decisions to stick with him.
  15. Bill Ackman's Assault on Herbalife Fizzles

    July 19, 2016
    The FTC's settlement and the subsequent rise in Herbalife stock is a major blow to Ackman, whose hedge fund is on a losing ...
  16. Sequoia Fund Exits Entire Valeant Stake

    July 14, 2016
    With Valeant stock rebounding almost 18% just in the past five days and rising 25% from its low through Tuesday's close, ...
  17. Valeant Surges 16% Since Walgreens Is "Satisfied"

    July 6, 2016
    The talks between the two companies have been positive. Short sellers were scrambling on Wednesday to cover their bets.
  18. Ackman's Pershing Square Down 20%

    July 6, 2016
    The firm also let go of 10% of its back-office staff.
  19. Brexit Fallout: Outlooks Diverge on Valeant (VRX)

    July 5, 2016
    Patient investors can gain 22%, according to BMO analysts, but other firms see major global risk ahead related to Brexit ...
  20. Ackman vs. Madoff: Who's Hurting Hedge Funds More?

    July 1, 2016
    Compare the plights of former and current money managers Bernie Madoff and Bill Ackman and how the actions of both men have ...
  21. More Bad News for Ackman? (PSHZF)

    July 1, 2016
    Discover reasons why Bill Ackman's Pershing Square may suffer again in 2016 due to Saudi Arabia's move to ban derivatives ...
  22. Is Einhorn Investing in the Next Valeant Stock? (VRX)

    June 29, 2016
    Learn why famed hedge fund manager David Einhorn initiated a long position in Mylan despite regulatory concerns about the ...
  23. Brexit Could Impact Valeant's Asset Sales (VRX)

    June 28, 2016
    Britain's decision Friday to leave the European Union could negatively impact the company's divestment plans.
  24. Bill Ackman on Concentrated Portfolios, Lessons From Valeant ...

    June 27, 2016
    Explore the lessons of concentrated portfolios, including how Bill Ackman's strategy change at Pershing Square mirrors one ...
  25. Valeant Falls As Barclays Sees 'No Short-Term Fix' (VRX, WBA)

    June 16, 2016
    Beyond poor deals, Valeant's acquisition spree, which has ballooned its debt level to over $31 billion, remains a drag on ...
  26. Valeant's CEO Joseph Papa Buys 202,000 Shares (VRX)

    June 14, 2016
    Joseph Papa affirmed Monday that he believes in his own turnaround strategy for Valeant.
  27. Index Funds: The Case Against Bill Ackman (STT, BLK)

    June 11, 2016
    Explore the reasoning behind Bill Ackman's concern of an impending index fund bubble, and why his argument sounds like an ...
  28. Valeant: Why Drug Price Cuts Not Seen Yet (VRX, WBA)

    June 10, 2016
    Learn the details of the Valeant scandal, look into the Citron accusations and Valeant's defense, and find out where Valeant ...
  29. Valeant's Positive Aspects Overlooked: Analyst (VRX)

    June 9, 2016
    Guggenheim's comments come on the heels of Valeant suffering massive declines in two of the company's key categories, dermatology ...
  30. The Market In 5 Minutes: We're Gathered Here To Get Through This ...

    June 7, 2016
    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
  31. Valeant Stock Falls on Wider Loss, Guidance Miss (VRX)

    June 7, 2016
    Combined with weak guidance for the second quarter, the optimism recently created from the arrival of its new CEO seems to ...
  32. Bill Ackman's Pershing Square Down 18.6% as of May

    June 6, 2016
    Betting on a Pershing Square recovery is a bet not only Bill Ackman, it's also a wager that Valeant can eventually get its ...
  33. Valeant Stock Rises Ahead of Q1 Earnings (VRX)

    June 6, 2016
    Wall Street expects the beleaguered drug company to deliver a year-over-year decline in earnings, while revenue is expected ...
  34. Bill Ackman Is Against Mutual Funds: Should Investors Listen? ...

    June 5, 2016
    Learn about Bill Ackman's view of index funds and how passive management ignores stock valuation, leading U.S. equities to ...
  35. 3 Lessons From Hedge Funds' Favorite Stocks (HTZ, VRX, SUNEQ)

    June 4, 2016
    Learn about the increasing influence of hedge fund managers on investors and how the stock selection of the pros should always ...
  36. The Legal Way to Get a Bigger Bonus Than You Earned

    June 1, 2016
    Non-GAAP metrics already have some investors riled up. But what happens when companies determine executive pay using “earnings ...
  37. Biotech Stocks: Are They Back?

    June 1, 2016
    The bearish trends over the past year have started to reverse themselves which has benefted the biotech industry
  38. Valeant's Outgoing CEO Gets $9M Severance and More (VRX)

    June 1, 2016
    J. Michael Pearson, CEO of Valeant until May 2, will receive a $9 million severance payment. Valeant's stock has fallen 9 ...
  39. 4 Lessons Valeant Can Teach Investors (VRX)

    June 1, 2016
    Learn about the storied tumble of Valeant Pharmaceuticals Inc. and the subsequent effect on institutional and individual ...
  40. Valeant Stock Surges After Rejecting Takeover Bids (VRX)

    May 31, 2016
    The fact that there are interested buyers in the beleaguered drug company suggests Valeant still has some appreciable value.
  41. Biotech ETFs: Why Valeant May Cause Contagion Risk (VRX)

    May 26, 2016
    Learn about Valeant Pharmaceutical's scandal that caused its stock to plunge over 90%, and why biotech ETF investors should ...
  42. SEC Investigating Valeant's Use of Non-GAAP Metrics (VRX)

    May 25, 2016
    The SEC is not amused with Valeant's use of non-GAAP financial metrics.
  43. Valeant Gets Default Notice, Senior VP Resigns (VRX)

    May 23, 2016
    The filing delays are related to federal regulators investigating Valeant's accounting practices linked to its dealings with ...
  44. Valeant Falls After Questionable Bonus Payments (VRX)

    May 20, 2016
    Wells Fargo senior analyst David Maris has taken issue with what appears to be a brash statement by the embattled drug company.
  45. Valeant Stock Rises on Possible Asset Sale (VRX)

    May 18, 2016
    Whether these maneuvers will have any material effect on the company is not clear.
  46. Is the Hedge Fund Industry Peaking?

    May 14, 2016
    Learn if the hedge fund industry has crested, and explore the characteristics of the fund community that may have implications ...
  47. Valeant Stock Declines on Hospitals' Price Claims (VRX)

    May 13, 2016
    Shares of Valeant declined almost 11% Thursday after several hospitals complained they had not received promised drug discounts.
  48. Valeant Stock Plummets on Jim Chanos' Short Bet (VRX)

    May 9, 2016
    Famed short seller Jim Chanos last week fanned the flames of doubt about Valeant's future.
  49. 3 Catalysts That Will Drive AERI Higher in 2016 (AERI, VRX)

    May 8, 2016
    Read about the key drivers of Aerie Pharmaceuticals' stock price, which has been volatile since the company's IPO.
  50. 6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE)

    May 1, 2016
    Discover why the Russell 2000 and other investment indexes believe California-based Kythera Biopharmaceuticals Inc. is a ...
  51. Valeant Files Late Annual Report, Restates Results (VRX)

    April 29, 2016
    Valeant Pharmaceuticals filed its overdue 10-K form with the SEC Friday, restating revenues and profits for 2014 and much ...
  52. Valeant Announces New CEO (VRX)

    April 25, 2016
    The embattled Canadian drug maker announced that Joseph Papa, former CEO of Perrigo Co., would be its CEO this morning.
  53. (VRX) Who are Valeant's Main Competitors?

    April 23, 2016
    Learn which companies Valeant is likely watching closely, since it is known for acquiring companies for their products rather ...
  54. Top 3 Companies Owned by Valeant (VRX)

    April 23, 2016
    Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates ...
  55. Valeant News: Michael Pearson's Return, Sort of

    April 18, 2016
    Explore the circumstances surrounding Michael Pearson’s leave of absence from Valeant, as well as the details of his short-lived ...
  56. Valeant vs. Abbott Labs: Which Is Better for My Portfolio? (VRX, ...

    April 16, 2016
    Explore the differences between Abbott Laboratories and Valeant Pharmaceuticals, as well as which stock is the best addition ...
  57. Deconstructing Two Notorious Story Stocks (VRX, CMG)

    April 8, 2016
    Valeant and Chipotle are once-respected brands that have been undermined by scandals, but traders aren't complaining.
  58. Bill Ackman's Greatest Hits and Misses

    March 22, 2016
    With the recent Valeant fiasco, we take a look back at the best and worst of the gray haired hedge fund manager.
  59. Valeant CEO Steps Down (VRX)

    March 21, 2016
    The markets started on a lower note this morning as equity and commodity prices took a breather from recent rallies.
  60. FedEx Soars, Ackman Sells Mondelez (FDX, MDLZ)

    March 17, 2016
    Shares for FedEx (FDX) rose to their highest level in nearly three months after the logistics giant reported results that ...
  61. How Low Will Valeant Go? (VRX)

    March 16, 2016
    A week after its stock price surged, Valeant Pharmaceuticals International Inc. is down in the dumps once again.
  62. Markets Cautious Ahead of Tomorrow's Fed Meeting (VRX, DSW)

    March 15, 2016
    Declining oil prices and the Federal Reserve meeting are on the market's mind this morning.
  63. 4 Reasons Behind Bill Ackman's Purchase of Zoetis Stock (ZTS, ...

    March 15, 2016
    Find out the reasons behind activist hedge fund manager Bill Ackman's 10% stake in Zoetis, Inc., and learn his plans for ...
  64. Why Valeant Pharmaceuticals Surged 13% Last Week (VRX)

    March 14, 2016
    While VRX shares may look attractive today, take Person's "There is no other big shoe to drop" remark at your own peril.
  65. Bill Ackman's Success Story: Net Worth, Education & Top Quotes ...

    March 7, 2016
    Read about William Ackman, Pershing Square Capital Management's confident and brash portfolio manager and famous activist ...
  66. Canadian Authorities Could Be Looking Into Valeant

    March 1, 2016
    Regulators' involvement with Valeant Pharmaceuticals Intl Inc (NYSE: VRX) could last quite a while, according to John Gavin ...
  67. Top 5 Positions in John Paulson's Portfolio (AGN, VRX)

    February 29, 2016
    Find out which stocks are holding the top five positions in investment guru John Paulson's hedge fund portfolio and which ...
  68. 3 Volatile U.S. Industries to Exploit in 2016 (VRX, IBB)

    February 13, 2016
    Read about volatile sectors in the stock market that may provide opportunities for investors in 2016, including energy, mining ...
  69. Bill Ackman's 2 Best Investments (GGP, CP)

    February 10, 2016
    Learn about the two best investments Ackman ever made. Ackman has demonstrated a consistent track record of success in all ...
  70. Under Pressure: Eyeing Pershing Square's Holdings

    February 2, 2016
    A look at Pershing Square's recent performance, portfolio and future outlook. Should investors follow the money?
  71. Allergan: An Activist Investment Analysis (AGN,VRX)

    January 28, 2016
    Read about the activist investor campaign against Allergan by Bill Ackman. See how Ackman partnered with another drug company ...
  72. The Top 3 Biotechnology Stocks for 2016 (AMGN, VRX)

    December 30, 2015
    Find out more about the top three biotechnology stocks to consider in 2016, and learn about their characteristics and why ...
  73. Valeant Shares up on Walgreens Deal

    December 15, 2015
    Shares of Valeant Pharmaceuticals rose by 15% after it announced a new drug pricing and distribution agreement with Walgreens ...
  74. Congressman Questions VW's "Road of Deceit" (KING, ATV)

    November 3, 2015
    The U.S. EPA​ widened its probe against Volkswagen saying the car maker used the defeat device on other V6 engines to comply ...
  75. 3 Answers For Valeant Investors (VRX)

    October 26, 2015
    Valeant Pharmaceutical Inc., held an investor call to clarify its relationship with specialty pharmaceutical firms. Here ...
  76. Will Valeant's Mea Culpa Save Its Stock?

    October 26, 2015
    This morning, Canadian pharmaceutical maker Valeant Pharmaceuticals International Inc. (VRX) announced a public conference ...
  77. More Volatility Ahead

    September 29, 2015
    Yesterday started the week with a dose of fear as the VIX shot up by almost 17 percent. The index has been consistently trending ...
  78. Citron: 'The Real Problem With Drug Pricing In America Is Forged ...

    September 28, 2015
    Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were down more than 15 percent on Monday. The decline was triggered ...
  79. Valeant Pharmaceuticals acquires Sprout Pharmaceuticals (VRX)

    August 21, 2015
    On August 20, 2015, Valeant Pharmaceuticals (VRX) announced that they entered into definitive agreement to acquire Sprout ...
  80. Want to Beat the Market? Take on Some Risk

    July 8, 2015
    As we head into a sketchy investment environment, you may want to reverse your thinking to find the best opportunities.
  81. Most Important Mergers And Acquisitions Of 2015

    June 15, 2015
    Nearly halfway through the year, 2015 is proving to be a big one for mergers and acquisitions.
  82. Portfolio Manager Minyi Chen On Why Certain Companies Are Likely ...

    May 18, 2015
    Minyi Chen, portfolio manager of AdvisorShares TrimTabs Float Shrink ETF (NYSE: TTFS) said he believes certain companies ...
  83. Four Breakout Stocks To Watch

    February 19, 2014
    These biotechnology and pharmaceutical stocks continue to put in new highs, but indicators are diverging.
  84. Valeant Eyes Bausch & Lomb

    May 28, 2013
    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was ...
  85. Can The Big Gains Continue Into 2012?

    January 3, 2012
    Learn the opportunities and risks that await some top performers in 2012.
Trading Center